From ocular oncology to tackling neglected diseases, our 2020 Power Listers are making their mark on ophthalmology – and beyond.
The glaucoma subspecialty is now at a turning point, but new approaches, including MIGS, must be based on high-quality evidence
The DARPin platform has the AMD and DME treatment burden firmly in its sights – but that’s only the beginning
The latest ophthalmology research – in brief
The standard of care for wet AMD presents a big burden for patients, so what other options are out there?
Could the ELOVL2 gene be the key to new therapeutics for age-related eye diseases?
Fight for Sight unites the UK’s leading ophthalmologists to highlight a severe research funding gap
25 retina specialists, one pioneering model for international collaboration – this is the story of the International Retina Group
Michael D. Abramoff,
Four AI and deep learning gurus discuss the use of these advanced technologies in eye care – and predict where they may take us next
Researchers shed light on how dscaml1 deficiency affects neural development and eye movements in zebrafish
Drugs used to treat retinal disorders appear to pass into breast milk, posing a potential risk to the normal development of nursing infants
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.